Clinical Trials in Minneapolis

Showing 8461-8480 of 14,456 trials

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

NCT00605826

The purpose of this study is to determine the effectiveness and safety of NASHA/Dx when used as an injectable bulking agent in the treatment of fecal incontinence. The study includes a 6-month blinded sham-controlled phase, followed by an open-label phase.

Fecal Incontinence

Bausch Health Americas, Inc.206 participantsStarted Sep 2006

San Francisco, California, United States • Tampa, Florida, United States • Burlington, Massachusetts, United States +10 more locations

COMPLETEDPhase 3< 1 mile

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

NCT00005970

This randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and trastuzumab to see how well they work compared to combination chemotherapy alone in treating women with breast cancer that is human epidermal growth factor receptor 2 (HER2)-positive and has spread to the lymph nodes or high-risk and has not spread to the lymph nodes. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether combination chemotherapy is more effective with or without trastuzumab in treating breast cancer.

Breast AdenocarcinomaHER2 Positive Breast CarcinomaStage IA Breast Cancer AJCC v7+4 more

National Cancer Institute (NCI)3,436 participantsStarted May 2000

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +154 more locations

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Find Trials by Condition in Minneapolis

Laser 360iQ: Optimal Light-laser Combination Therapy

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents

Electrical Activation of The Diaphragm for Ventilatory Assist

The DIVERT-CARE (Collaboration Action Research & Evaluation) Trial

Clinical and Device Functional Assessment of Real World ICD Patients

A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence